Your browser doesn't support javascript.
loading
Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans.
Meng, Jian; Zhang, Hua; Bao, Jing-Jing; Chen, Zhen-Dong; Liu, Xiao-Yun; Zhang, Yi-Fan; Jiang, Yong; Miao, Li-Yan; Zhong, Da-Fang.
Afiliação
  • Meng J; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Zhang H; The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Bao JJ; Shanghai Allist Pharmaceuticals Inc., Shanghai, 201203, China.
  • Chen ZD; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Liu XY; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Zhang YF; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Jiang Y; Shanghai Allist Pharmaceuticals Inc., Shanghai, 201203, China.
  • Miao LY; The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Zhong DF; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China. dfzhong@simm.ac.cn.
Acta Pharmacol Sin ; 43(2): 494-503, 2022 Feb.
Article em En | MEDLINE | ID: mdl-33927359

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article